Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy

BACKGROUND: We report the first case of pediatric bilateral blue laser pointer maculopathy with complete resolution of visual symptoms. CASE: A 12-year-old boy presented with bilateral decreased visual acuity and central scotomata after blue laser pointer exposure. He was treated with a Medrol Dosep...

Descripción completa

Detalles Bibliográficos
Autores principales: Raevis, Joseph, Shrier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465743/
https://www.ncbi.nlm.nih.gov/pubmed/28611647
http://dx.doi.org/10.1159/000460289
_version_ 1783242993690476544
author Raevis, Joseph
Shrier, Eric
author_facet Raevis, Joseph
Shrier, Eric
author_sort Raevis, Joseph
collection PubMed
description BACKGROUND: We report the first case of pediatric bilateral blue laser pointer maculopathy with complete resolution of visual symptoms. CASE: A 12-year-old boy presented with bilateral decreased visual acuity and central scotomata after blue laser pointer exposure. He was treated with a Medrol Dosepak and topical nonsteroidal anti-inflammatory drug (NSAID), with gradual visual acuity improved from 20/40 OU to 20/20 OU over 22 weeks, but with persistent evidence of outer retinal layer disruption from the external limiting membrane to the interdigitation zone. CONCLUSION: Oral steroids and topical NSAIDs may be effective in improving visual outcomes in laser pointer maculopathy in the pediatric population.
format Online
Article
Text
id pubmed-5465743
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54657432017-06-13 Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy Raevis, Joseph Shrier, Eric Case Rep Ophthalmol Case Report BACKGROUND: We report the first case of pediatric bilateral blue laser pointer maculopathy with complete resolution of visual symptoms. CASE: A 12-year-old boy presented with bilateral decreased visual acuity and central scotomata after blue laser pointer exposure. He was treated with a Medrol Dosepak and topical nonsteroidal anti-inflammatory drug (NSAID), with gradual visual acuity improved from 20/40 OU to 20/20 OU over 22 weeks, but with persistent evidence of outer retinal layer disruption from the external limiting membrane to the interdigitation zone. CONCLUSION: Oral steroids and topical NSAIDs may be effective in improving visual outcomes in laser pointer maculopathy in the pediatric population. S. Karger AG 2017-03-07 /pmc/articles/PMC5465743/ /pubmed/28611647 http://dx.doi.org/10.1159/000460289 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Raevis, Joseph
Shrier, Eric
Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title_full Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title_fullStr Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title_full_unstemmed Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title_short Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy
title_sort pediatric bilateral blue laser pointer-induced maculopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465743/
https://www.ncbi.nlm.nih.gov/pubmed/28611647
http://dx.doi.org/10.1159/000460289
work_keys_str_mv AT raevisjoseph pediatricbilateralbluelaserpointerinducedmaculopathy
AT shriereric pediatricbilateralbluelaserpointerinducedmaculopathy

Ejemplares similares